Babak Barcohana, MD
Orthopaedic Surgery of the Spine · van Nuys, CANPI 1659454841
Payments from drug & device makers
Across 118 payments — averaging $24,903 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Depuy Synthes Products, Inc.$2.8M
- Kyocera Medical Technologies, Inc.$58K
- Surgalign Spine Technologies, Inc.$17K
- Nexxt Spine LLC$10K
- Alphatec Spine, Inc$1K
- Baxter Healthcare$514
- plus $4K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Depuy Synthes Products, Inc. | 3 | $2,848,459 |
| Kyocera Medical Technologies, Inc. | 12 | $57,508 |
| Surgalign Spine Technologies, Inc. | 22 | $16,762 |
| Nexxt Spine LLC | 13 | $10,479 |
| Alphatec Spine, Inc | 3 | $1,123 |
| Baxter Healthcare | 5 | $514 |
| Highridge Medical LLC | 5 | $437 |
| Johnson & Johnson(2 entities) | 5 | $383 |
| Si-bone, Inc. | 3 | $371 |
| Xtant Medical Inc | 4 | $354 |
| Nevro Corp. | 3 | $285 |
| EBI, LLC | 3 | $280 |
| Spineart USA Inc | 2 | $260 |
| Boston Scientific | 3 | $200 |
| Relievant Medsystems, Inc. | 4 | $196 |
| Cerapedics Inc. | 2 | $176 |
| Amgen | 3 | $158 |
| Pfizer | 5 | $140 |
| Medacta USA, Inc. | 1 | $125 |
| Zimmer Biomet | 1 | $112 |
| Renovis Surgical Technologies, Inc. | 1 | $61 |
| IBSA Pharma Inc. | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27 |
| Carlsmed, Inc. | 1 | $24 |
| Providence Medical Technology, Inc. | 1 | $20 |
| Vertex | 1 | $20 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Stryker | 1 | $16 |
| Abbott | 1 | $15 |
| Prosidyan, Inc | 6 | $0 |
How this compares
$2,938,565 in reported general payments places this provider in the 95th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery of the spine in van Nuys
- Brian Grossmanvan Nuys$415K
- Hyun BaeSanta Monica$62.2M
- Choll KimSan Diego$4M
- Stacey BedermanOrange$3.7M
- Gregory Mundisla Jolla$3.5M
- Neelakantan AnandLos Angeles$3.2M
- Paul SlosarDaly City$3.1M
- Rick DelamarterSanta Monica$2.3M
- Sanjay KhuranaMarina del Rey$2.3M
- Neville AlleyneOceanside$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.